GlassScriptPhysician profile
Tanu S Chandra
NPI 1568626182
$175.32
in general payments reported to CMS, 2019-2025
8 companies · $20.74 in 2025
The $20.74 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.22 · 2023: $142 · 2025: $20.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $31.44 | 2023 | Cequr Simplicity |
| Insulet Corporation | $28.05 | 2023 | Omnipod |
| Ascensia Diabetes Care US INC. | $26.45 | 2023 | |
| Medtronic, INC. | $22.20 | 2023 | Minimed 780g |
| Amgen INC. | $21.16 | 2023 | Evenity, Prolia |
| Corcept Therapeutics | $20.74 | 2025 | Korlym |
| Tandem Diabetes Care, INC. | $13.06 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanu Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.